197 related articles for article (PubMed ID: 15814634)
41. CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer.
Cabioglu N; Yazici MS; Arun B; Broglio KR; Hortobagyi GN; Price JE; Sahin A
Clin Cancer Res; 2005 Aug; 11(16):5686-93. PubMed ID: 16115904
[TBL] [Abstract][Full Text] [Related]
42. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
43. Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC).
Holm NT; Abreo F; Johnson LW; Li BD; Chu QD
Breast Cancer Res Treat; 2009 Jan; 113(2):293-9. PubMed ID: 18270814
[TBL] [Abstract][Full Text] [Related]
44. Expression of chemokine receptors in human gastric cancer.
Kwak MK; Hur K; Park DJ; Lee HJ; Lee HS; Kim WH; Lee KU; Choe KJ; Yang HK
Tumour Biol; 2005; 26(2):65-70. PubMed ID: 15867478
[TBL] [Abstract][Full Text] [Related]
45. [mRNA expression of chemokine receptors in hepatic and pancreatic tumor cell lines].
Masai K; Iwashita Y; Tominaga M; Hirano S; Shibata K; Matsumoto T; Sasaki A; Ohta M; Kitano S
Gan To Kagaku Ryoho; 2004 Aug; 31(8):1261-3. PubMed ID: 15332556
[TBL] [Abstract][Full Text] [Related]
46. Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma.
Uchibori M; Nishida Y; Nagasaka T; Yamada Y; Nakanishi K; Ishiguro N
Int J Oncol; 2006 Jan; 28(1):33-42. PubMed ID: 16327977
[TBL] [Abstract][Full Text] [Related]
47. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
48. CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro.
Bajetto A; Barbieri F; Pattarozzi A; Dorcaratto A; Porcile C; Ravetti JL; Zona G; Spaziante R; Schettini G; Florio T
Neuro Oncol; 2007 Jan; 9(1):3-11. PubMed ID: 17108064
[TBL] [Abstract][Full Text] [Related]
49. Expression of haematogenous and lymphogenous chemokine receptors and their ligands on uveal melanoma in association with liver metastasis.
Dobner BC; Riechardt AI; Joussen AM; Englert S; Bechrakis NE
Acta Ophthalmol; 2012 Dec; 90(8):e638-44. PubMed ID: 23164171
[TBL] [Abstract][Full Text] [Related]
50. Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor.
Yang SX; Chen JH; Jiang XF; Wang QL; Chen ZQ; Zhao W; Feng YH; Xin R; Shi JQ; Bian XW
Biochem Biophys Res Commun; 2005 Sep; 335(2):523-8. PubMed ID: 16084492
[TBL] [Abstract][Full Text] [Related]
51. CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival.
Mirisola V; Zuccarino A; Bachmeier BE; Sormani MP; Falter J; Nerlich A; Pfeffer U
Eur J Cancer; 2009 Sep; 45(14):2579-87. PubMed ID: 19646861
[TBL] [Abstract][Full Text] [Related]
52. The expression of CXCR4 is down-regulated on the CD34+ cells of patients with myelofibrosis with myeloid metaplasia.
Rosti V; Massa M; Vannucchi AM; Bergamaschi G; Campanelli R; Pecci A; Viarengo G; Meli V; Marchetti M; Guglielmelli P; Bruno E; Xu M; Hoffman R; Barosi G; ;
Blood Cells Mol Dis; 2007; 38(3):280-6. PubMed ID: 17350297
[TBL] [Abstract][Full Text] [Related]
53. Involvement of E-cadherin, beta-catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma.
Tucci MG; Lucarini G; Brancorsini D; Zizzi A; Pugnaloni A; Giacchetti A; Ricotti G; Biagini G
Br J Dermatol; 2007 Dec; 157(6):1212-6. PubMed ID: 17970806
[TBL] [Abstract][Full Text] [Related]
54. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
Zhang Z; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Iwase H
Clin Cancer Res; 2006 Nov; 12(21):6410-4. PubMed ID: 17085653
[TBL] [Abstract][Full Text] [Related]
55. Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents.
Buddingh EP; Kuijjer ML; Duim RA; Bürger H; Agelopoulos K; Myklebost O; Serra M; Mertens F; Hogendoorn PC; Lankester AC; Cleton-Jansen AM
Clin Cancer Res; 2011 Apr; 17(8):2110-9. PubMed ID: 21372215
[TBL] [Abstract][Full Text] [Related]
56. Telomerase expression predicts unfavorable outcome in osteosarcoma.
Sanders RP; Drissi R; Billups CA; Daw NC; Valentine MB; Dome JS
J Clin Oncol; 2004 Sep; 22(18):3790-7. PubMed ID: 15365076
[TBL] [Abstract][Full Text] [Related]
57. Expression of matrix metalloproteinase regulator, RECK, and its clinical significance in osteosarcoma.
Xu J; Wu S; Shi X
J Orthop Res; 2010 Dec; 28(12):1621-5. PubMed ID: 20973064
[TBL] [Abstract][Full Text] [Related]
58. Expression of platelet-derived growth factor-AA is associated with tumor progression in osteosarcoma.
Sulzbacher I; Birner P; Trieb K; Träxler M; Lang S; Chott A
Mod Pathol; 2003 Jan; 16(1):66-71. PubMed ID: 12527715
[TBL] [Abstract][Full Text] [Related]
59. Chemokine IL-8 and chemokine receptor CXCR3 and CXCR4 gene expression in childhood acute lymphoblastic leukemia at first relapse.
Wu S; Gessner R; Taube T; Korte A; von Stackelberg A; Kirchner R; Henze G; Seeger K
J Pediatr Hematol Oncol; 2006 Apr; 28(4):216-20. PubMed ID: 16679918
[TBL] [Abstract][Full Text] [Related]
60. Coexpression of CXCR4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma.
Ren Z; Liang S; Yang J; Han X; Shan L; Wang B; Mu T; Zhang Y; Yang X; Xiong S; Wang G
Tumour Biol; 2016 Apr; 37(4):5089-96. PubMed ID: 26546437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]